ALPA

Alpa Laboratories Share Price

₹108.78 +1.6 (1.49%)

17 May, 2025 08:51

SIP TrendupStart SIP in ALPA

Start SIP

Performance

  • Low
  • ₹107
  • High
  • ₹111
  • 52 Week Low
  • ₹70
  • 52 Week High
  • ₹145
  • Open Price₹108
  • Previous Close₹107
  • Volume26,305

Investment Returns

  • Over 1 Month -0.64%
  • Over 3 Month + 2.31%
  • Over 6 Month + 0.22%
  • Over 1 Year + 21.88%
SIP Lightning

Smart Investing Starts Here Start SIP with Alpa Laboratories for Steady Growth!

Invest Now

Alpa Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 9.1
  • PEG Ratio
  • 0.2
  • Market Cap Cr
  • 229
  • P/B Ratio
  • 1.4
  • Average True Range
  • 4.53
  • EPS
  • 11.99
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.96
  • RSI
  • 55.98
  • MFI
  • 55.63

Alpa Laboratories Financials

Alpa Laboratories Technicals

EMA & SMA

Current Price
₹108.78
+ 1.6 (1.49%)
pointer
  • stock-down_img
  • Bearish Moving Average 4
  • stock-up_img
  • Bullish Moving Average 12
  • 20 Day
  • ₹105.54
  • 50 Day
  • ₹107.09
  • 100 Day
  • ₹108.99
  • 200 Day
  • ₹107.86

Resistance and Support

108.94 Pivot Speed
  • R3 114.64
  • R2 112.79
  • R1 110.79
  • S1 106.94
  • S2 105.09
  • S3 103.09

What's your outlook on Alpa Laboratories?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Alpa Laboratories has an operating revenue of Rs. 96.14 Cr. on a trailing 12-month basis. An annual revenue growth of 21% is outstanding, Pre-tax margin of 19% is great, ROE of 11% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 92 which is a GREAT score indicating consistency in earnings, a RS Rating of 72 which is FAIR indicating the recent price performance, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 70 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Alpa Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-02-13 Quarterly Results & Others To consider other business matters.
2024-11-14 Quarterly Results
2024-08-13 Quarterly Results & A.G.M.
2024-05-28 Audited Results
2024-02-13 Quarterly Results

Alpa Laboratories F&O

Alpa Laboratories Shareholding Pattern

57.29%
0.4%
37.32%
4.99%

About Alpa Laboratories

  • NSE Symbol
  • ALPA
  • BSE Symbol
  • 532878
  • Managing Director
  • Mr. Paresh Chawla
  • ISIN
  • INE385I01010

Similar Stocks to Alpa Laboratories

Alpa Laboratories FAQs

Alpa Laboratories share price is ₹108 As on 17 May, 2025 | 08:37

The Market Cap of Alpa Laboratories is ₹228.9 Cr As on 17 May, 2025 | 08:37

The P/E ratio of Alpa Laboratories is 9.1 As on 17 May, 2025 | 08:37

The PB ratio of Alpa Laboratories is 1.4 As on 17 May, 2025 | 08:37

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23